Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer

Figure 6

Immunohistochemistry study. Neoplastic cell positivity for WT1 (a), RE (80%) (b), RP (80%) (c), p53 wild-type labeling (faint 60%) (d), p16 (70%) (e), Ki-67 30% (f), and AR showing diffuse positivity (g) (100x).

(a)

(b)

(c)

(d)

(e)

(f)

(g)